Complexa Competitors and Similar CompaniesClear all
Complexa's competitors and similar companies include Immatics and Synthorx.
 Complexa Complexa is a biopharmaceutical company, developing therapies for the treatment of inflammatory, and metabolic diseases. |  Immatics Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer. |  Synthorx Synthorx is a biotechnology company using synthetic biology starting with its novel DNA base pair to discover and develop new protein therapeutics. | |
Founding Date | Founding Date 2008 | Founding Date N/A | Founding Date 2014 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Berwyn, US HQ | Locations Tübingen, DE HQ Frankfurt Am Main, DE München, DE Houston, US | Locations San Diego, US HQ |
Employees | Employees 9 | Employees 29723% increase | Employees 3939% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.1 b | Valuation ($) 2.2 b |
Financial | |||
Net income | Net income N/A | Net income (€196.4m) (FY, 2025) | Net income ($5.9m) (FY, 2017) |
Funding | |||
Total funding raised | Total funding raised $ 79m | Total funding raised $ 267.3m | Total funding raised $ 79m |
For sources of this data, please see the company profile
View Company Profiles
Immatics
HQ
Tübingen, DE
Employees
297↑ 23% increase
Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer.
View companySynthorx
HQ
San Diego, US
Employees
39↑ 39% increase
Synthorx is a biotechnology company using synthetic biology starting with its novel DNA base pair to discover and develop new protein therapeutics.
View company